EGFR and cancer: The results of the chi-square analysis for the odds ratios of overall ADR and grade 3 or 4 ADR by gender, age, histological subtype of cancer, clinical stage, EGFR mutation, PD-L1, Hepatitis B virus and timing of treatment are reported in Table 6.